Beyond-White-Label Model Expands To Med Spas and Health Tech Builders

FOR IMMEDIATE RELEASE

Austin, TX – June 5th, 2026

GeneMetrics, a white-label genetic testing platform built for healthcare practitioners and wellness brands, has announced the expanded availability of its Beyond-White-Label™ model, allowing licensed clinics, medical spas, supplement companies, and health technology builders to deploy fully branded DNA testing services in as little as 72 hours. The offering spans end-to-end fulfillment, covering kit logistics, laboratory processing, bioinformatics pipelines, and patient-facing report generation, all presented under the client’s own brand name. Clients retain full ownership of their data throughout the entire process.

KEY FACTS

72-hour launch window for new branded genetic testing platforms using GeneMetrics’ end-to-end fulfillment model

HIPAA and GDPR compliant infrastructure with multi-level encryption across all data handling and storage layers

Customizable sequencing depth ranging from targeted panel diagnostics to whole genome sequencing, configurable per client use case

Clients own their data: GeneMetrics does not retain, resell, or license patient genomic data to third parties

Pharmacogenomics testing included as a configurable module, enabling medication response insights for clinical practitioners

Zero lab infrastructure required: bioinformatics, report generation, and logistics are fully managed by GeneMetrics

The Infrastructure Problem Practitioners Actually Face

For most licensed practitioners considering genetic testing, the barrier has rarely been patient demand. The primary obstacle has been operational complexity. Establishing a compliant genomics program from the ground up requires CLIA-certified laboratory partnerships, dedicated bioinformatics staff, regulatory alignment under HIPAA’s genomic data guidance, and patient-facing reporting designed to meet clinical communication standards. According to a 2024 report by KLAS Research on specialty diagnostic adoption, operational complexity and upfront infrastructure cost are cited as the top two reasons ambulatory clinics delay or abandon specialty testing programs entirely.

GeneMetrics addresses this directly through its Beyond-White-Label™ model, which extends well beyond co-branded kit fulfillment. Clients configure their sequencing scope – from pharmacogenomics panels relevant to prescribing practitioners, to multi-marker wellness panels suited for medical spas, to broader whole-genome options for health technology integrations – and receive a fully managed back end with no laboratory buildout required. The result is a branded genetic testing product that a clinic or wellness brand can present to patients as entirely their own, supported by GeneMetrics’ clinical and bioinformatics infrastructure. Practitioners evaluating whether this approach suits their practice can find an honest tradeoff analysis for health professionals comparing white-label DNA testing against the available alternatives.

Where Practitioners Report the Clearest Value

Consider a scenario familiar to many integrative medicine clinic owners: a practitioner adds a nutrigenomics panel to her existing supplement protocol consultations. Previously, she referred patients to direct-to-consumer services, losing both the revenue opportunity and control over how results were communicated. Using GeneMetrics’ platform, she launched a fully branded “Precision Wellness” test under her clinic name within three days of onboarding, with actionable reports formatted for patient comprehension and clinical follow-up rather than the consumer-facing ancestry framing that direct-to-consumer services typically prioritize. Practitioners using this approach report an average of two to three additional consultation touchpoints per patient per year, driven by report-guided follow-up care.

A genuine tradeoff is worth noting: the 72-hour launch timeline applies to practitioners adopting a standard configuration. Clients requiring deep custom bioinformatics pipelines, novel biomarker panels, or health app API integrations should anticipate a longer scoping and implementation phase. GeneMetrics positions its platform as the appropriate fit for practitioners ready to deploy proven genetic insight frameworks, rather than as a bespoke research and development partner for novel diagnostic development. Teams moving too quickly without adequate planning risk making the white-label DNA testing mistakes that can undermine promising programs before they launch.

Data Ownership as a Clinical and Competitive Differentiator

At a time when genomic data privacy is facing increased regulatory scrutiny – including proposed amendments to HIPAA’s definition of protected health information to explicitly cover genomic identifiers currently under HHS review – the question of who owns patient data is no longer a fine-print concern. GeneMetrics structures all client agreements around a clear principle: client organizations retain full ownership of the genomic data generated through their branded platform. GeneMetrics does not use that data for secondary research, third-party licensing, or model training. The technical architecture behind this commitment is detailed in GeneMetrics’ documentation on multi-tenant isolation, bioinformatics throughput, and HIPAA-compliant delivery at scale.

“Most practitioners don’t realize that when they refer patients to a direct-to-consumer platform, they’ve ceded both the revenue and the data relationship,” said a GeneMetrics platform lead. “Our model inverts that. The practitioner’s brand is on the report, the data lives in their account, and the patient relationship stays exactly where it belongs: with the provider.”

“The 72-hour benchmark is real, but what matters more is what happens after launch,” added a member of GeneMetrics’ client implementation team. “We built the fulfillment layer so practitioners can focus on interpreting insights and building patient relationships, not on managing kit inventory or chasing lab turnaround times.”

About GeneMetrics

GeneMetrics is a white-label genetic testing platform that enables licensed healthcare practitioners, clinics, wellness brands, and health technology companies to offer fully branded DNA testing services without building laboratory infrastructure. The company’s Beyond-White-Label™ model covers end-to-end fulfillment, including laboratory processing, bioinformatics analysis, and clinically backed report generation, under each client’s own brand. GeneMetrics operates under HIPAA and GDPR compliance frameworks with multi-level data encryption, and clients retain full ownership of all genomic data generated through their platforms. Learn more at genemetrics.com.

Media Contact

GeneMetrics

6507 Jester Blvd

Austin, Texas 78750

United States

Chris Haas

+1 898202601

https://genemetrics.com

Contact Information:

GeneMetrics

Texas
Austin, Texas 78701
United States

Chris Haas
+1 1898202601
https://genemetrics.com